Fresenius SE & Co. KGaA Sponsored ADR (FSNUY)
OTC
Closed
Aug 24, 2026
Day's Range
13.4552 wk Range
10.33Overview - FSNUY - Fresenius SE & Co. KGaA Sponsored ADR
Key Statistics
Valuation
Enterprise Value
48.53B
P/E (Trailing)
‪16.67‬
P/E (Forward)
‪4.68‬
PEG Ratio
‪0.96‬
Price / Sales (TTM)
‪1.30‬
Price / Book
‪1.32‬
EV / EBITDA
‪13.67‬
Profitability
Gross Margin
‪26.07%‬
Profit Margin
‪6.53%‬
Operating Margin
‪10.63%‬
Return on Assets
‪3.43%‬
Return on Equity
‪8.28%‬
Ownership
Shares Outstanding
563.23M
Float
1.64B
Held by Insiders
‪0.00%‬
Held by Institutions
‪0.0030%‬
Price stats
Beta
‪0.83‬
50-Day Avg
‪12.41‬
200-Day Avg
‪13.19‬
Dividends
Payout Ratio
‪37.75%‬
Frequency
Annual
Analyst Consensus
3 analysts
Average price target
‪$ 16.11‬Shariah Compliance
Report Date: Feb 17, 2025
Screened by Zoya using the AAOIFI methodology.
Market Cap - FSNUY - Fresenius SE & Co. KGaA Sponsored ADR
Peers - FSNUY - Fresenius SE & Co. KGaA Sponsored ADR
Peer Comparison
Compared with companies in Medical Care Facilities listed on OTC.
Profile Summary - FSNUY - Fresenius SE & Co. KGaA Sponsored ADR
About
Fresenius SE & Co. KGaA Sponsored ADR is a type of financial asset known as an American Depositary Receipt (ADR), representing shares in the German healthcare company, Fresenius SE & Co. KGaA. ADRs enable U.S. investors to access foreign companies' securities more easily. The primary purpose of this ADR is to…
The information on this page is provided for general informational purposes only and is not investment advice.
Market data provided by Twelve Data. Shariah compliance data provided by Zoya. Charting by TradingView.
Last updated:
